[HTML][HTML] Alzheimer's disease CSF biomarkers: clinical indications and rational use

E Niemantsverdriet, S Valckx, M Bjerke… - Acta neurologica …, 2017 - Springer
This review focusses on the validation and standardization of Alzheimer’s disease (AD)
cerebrospinal fluid (CSF) biomarkers, as well as on the current clinical indications and rational …

Association between repeat sizes and clinical and pathological characteristics in carriers of C9ORF72 repeat expansions (Xpansize-72): a cross-sectional cohort …

…, M DeJesus-Hernandez, E Niemantsverdriet… - The Lancet …, 2013 - thelancet.com
Background Hexanucleotide repeat expansions in chromosome 9 open reading frame 72 (C9ORF72)
are the most common known genetic cause of frontotemporal dementia (FTD) and …

[HTML][HTML] Consensus guidelines for lumbar puncture in patients with neurological diseases

S Engelborghs, E Niemantsverdriet, H Struyfs… - Alzheimer's & Dementia …, 2017 - Elsevier
Introduction Cerebrospinal fluid collection by lumbar puncture (LP) is performed in the diagnostic
workup of several neurological brain diseases. Reluctance to perform the procedure is …

Intervention with methotrexate in patients with arthralgia at risk of rheumatoid arthritis to reduce the development of persistent arthritis and its disease burden (TREAT …

…, TWJ Huizinga, CF Allaart, E Niemantsverdriet… - The Lancet, 2022 - thelancet.com
Background Rheumatoid arthritis is the most common autoimmune disease worldwide and
requires long-term treatment to suppress inflammation. Currently, treatment is started when …

[HTML][HTML] Association of short-term cognitive decline and MCI-to-AD dementia conversion with CSF, MRI, amyloid-and 18F-FDG-PET imaging

J Ottoy, E Niemantsverdriet, J Verhaeghe… - NeuroImage: Clinical, 2019 - Elsevier
Disease-modifying treatment trials are increasingly advanced to the prodromal or preclinical
phase of Alzheimer's disease (AD), and inclusion criteria are based on biomarkers rather …

[HTML][HTML] The cerebrospinal fluid Aβ 1–42/Aβ 1–40 ratio improves concordance with amyloid-PET for diagnosing Alzheimer's disease in a clinical setting

E Niemantsverdriet, J Ottoy, C Somers… - Journal of …, 2017 - content.iospress.com
Background: Evidence suggests that the concordance between amyloid-PET and cerebrospinal
fluid (CSF) amyloid-ß (Aß) increases when the CSF Aß1–42/Aß1–40 ratio is used as …

[HTML][HTML] Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and-negative rheumatoid arthritis patients over 25 years: a …

XME Matthijssen, E Niemantsverdriet… - PLoS …, 2020 - journals.plos.org
Background Based on different genetic and environmental risk factors and histology, it has
been proposed that rheumatoid arthritis (RA) consists of 2 types: autoantibody-positive and …

Associating Alzheimer's disease pathology with its cerebrospinal fluid biomarkers

…, A Sieben, A Rozemuller, E Niemantsverdriet… - Brain, 2022 - academic.oup.com
Alzheimer’s disease CSF biomarkers 42 amino acid long amyloid-β peptide (Aβ 1–42 ),
total tau protein (T-tau), and tau protein phosphorylated at threonine 181 (P-tau 181 ) are …

[HTML][HTML] Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset

…, CE Teunissen, E Niemantsverdriet… - Translational …, 2020 - nature.com
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder and the most
common form of dementia in the elderly. Susceptibility to AD is considerably determined by …

[PDF][PDF] Imaging detected tenosynovitis of metacarpophalangeal and wrist joints: an increasingly recognised characteristic of rheumatoid arthritis

E Niemantsverdriet… - Clin Exp …, 2018 - clinexprheumatol.org
Tenosynovitis is traditionally recognised at physical examination in patients with inflammatory
rheumatic diseases, such as, eg psoriatic arthritis and (longstanding) rheumatoid arthritis (…